This grant opportunity from the National Institutes of Health supports assay validation of high quality markers for clinical studies in cancer. UH2/UH3 clinical trials are not allowed under this funding. Specific eligibility and detailed description are not provided, so applicants should consult the NIH for more information.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
